Chris Chen
biotechnology
Wuxi AppTec
China
Biography
Over 18 years' experience in large scale cell culture development and manufacturing and mab/vaccine development, formerly CEO of Shanghai Kanda Biotechnology; COO of Shanghai Celgen; Director of Process Science and Production at Eli Lilly/AME, Manager of BioProcess Technology at Merck. Ph.D. from University of Delaware, B.S. from Tsinghua University.
Research Interest
BioProcess Technology
